Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,56%
1 085,41
-6,10
-0,56%
—1 091,511 090,401 090,401 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,44%
607,40
-2,71
-0,44%
—610,11610,11610,11606,21——
SIXE
Energy
SIXE
Energy
SIXE
+0,00%
1 238,02
+0,040
+0,00%
—1 237,981 237,831 240,241 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,08%
1 746,08
+1,37
+0,08%
—1 744,711 740,951 745,141 735,64——
SIXM
Financials
SIXM
Financials
SIXM
-0,11%
639,46
-0,72
-0,11%
—640,18639,92639,92636,70——
SIXR
Staples
SIXR
Staples
SIXR
-0,27%
847,32
-2,26
-0,27%
—849,58845,27847,19841,28——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,07%
217,33
-0,15
-0,07%
—217,48217,48217,48216,39——
SIXT
Technology
SIXT
Technology
SIXT
+0,63%
3 281,27
+20,58
+0,63%
—3 260,693 273,363 286,293 269,07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,20%
944,38
+1,93
+0,20%
—942,45939,39943,48934,04——
SIXV
Health care
SIXV
Health care
SIXV
-0,11%
1 465,20
-1,60
-0,11%
—1 466,801 464,701 466,161 458,68——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,21%
2 402,53
+5,03
+0,21%
—2 397,502 395,032 402,502 392,78——
Q1 2026 earnings • 8:00 AM tomorrow
See details
BNTX:NASDAQ
BioNTech SE - ADR
98,88 $
+1,37%
(+1,33) 1D
4 մյս, 10:11:44 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTX...
Open
98,88 $
High
99,99 $
Low
97,95 $
Mkt. cap
24,99 մլրդ
Volume
120,99 հզր
52-wk high
124,00 $
52-wk low
79,52 $
EPS
-5,51 $
Beta
1,34
Shares outstanding
252,88 մլն
No. of employees
8 հզր
News stories
From sources across the web
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
CEOUğur Şahin
Employees7,81 հզր
Founded2008
Headquarters-
Sector-
Websitebiontech.de
Next call in 21:48:01
Tomorrow, 08:00
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-1,92 est.)EUR
Revenue / Estimate
-/ (155,38 մլն est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
182,80 մլն
260,80 մլն
1,52 մլրդ
907,40 մլն
Cost of goods sold
83,80 մլն
76,40 մլն
148,30 մլն
302,80 մլն
Cost of revenue
83,80 մլն
76,40 մլն
148,30 մլն
302,80 մլն
Research and development expenses
525,60 մլն
509,10 մլն
564,80 մլն
505,40 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120,60 մլն
137,40 մլն
148,50 մլն
217,90 մլն
Operating expense
593,40 մլն
621,10 մլն
1,40 մլրդ
907,20 մլն
Total operating expenses
677,20 մլն
697,50 մլն
1,55 մլրդ
1,21 մլրդ
Operating income
-494,40 մլն
-436,70 մլն
-33,00 մլն
-302,60 մլն
Other non operating income
122,60 մլն
105,40 մլն
96,80 մլն
-173,80 մլն
EBT including unusual items
-445,40 մլն
-402,70 մլն
24,70 մլն
-227,40 մլն
EBT excluding unusual items
-419,50 մլն
-379,30 մլն
40,70 մլն
-206,50 մլն
Income tax expense
-29,60 մլն
-16,10 մլն
53,40 մլն
77,60 մլն
Effective tax rate
6,65%
4,00%
216,19%
-34,12%
Other operating expenses
-52,80 մլն
-25,40 մլն
690,30 մլն
183,90 մլն
Net income
-415,80 մլն
-386,60 մլն
-28,70 մլն
-305,00 մլն
Net profit margin
-227,46%
-148,24%
-1,89%
-33,61%
Earnings per share
-1,73
-1,60
-0,12
-0,33
Interest and investment income
-
-
-
265,50 մլն
Interest expense
-7,90 մլն
-6,60 մլն
-2,60 մլն
-
Net interest expenses
-7,90 մլն
-6,60 մլն
-2,60 մլն
265,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-451,60 մլն
-385,70 մլն
91,20 մլն
-266,95 մլն
Gain or loss from assets sale
-100,00 հզր
-300,00 հզր
-1,30 մլն
-800,00 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer